These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8060249)

  • 21. Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit.
    Jeffrey RF; Khan AA; Douglas JT; Will EJ; Davison AM
    Artif Organs; 1993 Aug; 17(8):717-20. PubMed ID: 8215953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.
    Anastassiades E; Lane DA; Ireland H; Flynn A; Curtis JR
    Clin Nephrol; 1989 Dec; 32(6):290-6. PubMed ID: 2558829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of fondaparinux as an anticoagulant during hemodialysis: a preliminary study.
    Sombolos KI; Fragia TK; Gionanlis LC; Veneti PE; Bamichas GI; Fragidis SK; Georgoulis IE; Natse TA
    Int J Clin Pharmacol Ther; 2008 Apr; 46(4):198-203. PubMed ID: 18397694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintaining blood compartment volume in dialyzers reprocessed with peracetic acid maintains Kt/V but not beta2-microglobulin removal.
    Ouseph R; Smith BP; Ward RA
    Am J Kidney Dis; 1997 Oct; 30(4):501-6. PubMed ID: 9328364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of dialyzer reuse on dialysis delivery.
    Sherman RA; Cody RP; Rogers ME; Solanchick JC
    Am J Kidney Dis; 1994 Dec; 24(6):924-6. PubMed ID: 7985670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urea kinetics with dialyzer reuse--a prospective study.
    Sridhar NR; Ferrand K; Reger D; Hayes P; Pinnavaia L; Butts D; Kohli R; Papandenatos G
    Am J Nephrol; 1999; 19(6):668-73. PubMed ID: 10592361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Adequacy of Dialysis between Single-use and Reused Hemodialyzers in Patients on Maintenance Hemodialysis.
    Hamid A; Dhrolia MF; Imtiaz S; Qureshi R; Ahmad A
    J Coll Physicians Surg Pak; 2019 Aug; 29(8):720-723. PubMed ID: 31358090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of fiber bundle volume in reprocessed dialyzers.
    Narsipur SS
    Clin Nephrol; 2004 Feb; 61(2):130-3. PubMed ID: 14989633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On-line clearance: a useful tool for monitoring the effectiveness of the reuse procedure.
    Rahmati MA; Rahmati S; Hoenich N; Ronco C; Kaysen GA; Levin R; Levin NW
    ASAIO J; 2003; 49(5):543-6. PubMed ID: 14524561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
    McCarthy JT; Jenson BM; Squillace DP; Williams AW
    Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reprocessing high-flux polysulfone dialyzers does not negatively impact solute removal in short-daily online hemodiafiltration.
    Melo NC; Moyses RM; Elias RM; Castro MC
    Hemodial Int; 2014 Apr; 18(2):473-80. PubMed ID: 24393428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dialyzer reuse-Part I: Historical perspective.
    Twardowski ZJ
    Semin Dial; 2006; 19(1):41-53. PubMed ID: 16423181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodialyzer Reuse and Gram-Negative Bloodstream Infections.
    Edens C; Wong J; Lyman M; Rizzo K; Nguyen D; Blain M; Horwich-Scholefield S; Moulton-Meissner H; Epson E; Rosenberg J; Patel PR
    Am J Kidney Dis; 2017 Jun; 69(6):726-733. PubMed ID: 27940061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of dual dialyzers in parallel and series to improve urea clearance in large hemodialysis patients.
    Fritz BA; Doss S; McCann LM; Wrone EM
    Am J Kidney Dis; 2003 May; 41(5):1008-15. PubMed ID: 12722035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dialyzer-dependent changes in solute and water permeability with bleach reprocessing.
    Scott MK; Mueller BA; Sowinski KM; Clark WR
    Am J Kidney Dis; 1999 Jan; 33(1):87-96. PubMed ID: 9915272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical study to assess the effect of heparin in dialyzer rinsing solutions.
    Opatrný K; Bouda M; Kohoutková L; Vít L; Sefrna F
    Int J Artif Organs; 1997 Feb; 20(2):112-8. PubMed ID: 9093891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of heparin modeling on delivered hemodialysis therapy.
    Wei SS; Ellis PW; Magnusson MO; Paganini EP
    Am J Kidney Dis; 1994 Mar; 23(3):389-93. PubMed ID: 8128940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of dialyzer reuse and hospitalization rates among hemodialysis patients in the US.
    Feldman HI; Bilker WB; Hackett M; Simmons CW; Holmes JH; Pauly MV; Escarce JJ
    Am J Nephrol; 1999; 19(6):641-8. PubMed ID: 10592357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rebound kinetics of beta2-microglobulin after hemodialysis.
    Leypoldt JK; Cheung AK; Deeter RB
    Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis.
    Lindmarker P; Holmström M; Granqvist S; Johnsson H; Lockner D
    Thromb Haemost; 1994 Aug; 72(2):186-90. PubMed ID: 7831649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.